Related Experiment Video

Updated: Jun 30, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells

Jaume Barcelo1,2, Yumiko Teigen1,2, Joshua Alexander James Martin1,2

  • 1Cytoskeleton and Cancer Metastasis Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.

Iscience
|June 29, 2026
PubMed

Insights

Certain invasive cancer cells depend on Rho kinase (ROCK) and Myosin II for survival. ROCK inhibitors reduce survival in these cells, impacting tumor progression and offering pre-clinical insights.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Rho kinase (ROCK) signaling is implicated in tumor progression.
  • The specific reliance of certain cancer cells on ROCK-Myosin II for survival is not well understood.

Purpose of the Study:

  • To systematically analyze ROCK inhibitor sensitivity across various cancer cell lines.
  • To identify biomarkers for ROCK inhibitor sensitivity in solid tumors and hematological malignancies.
  • To elucidate the molecular mechanisms underlying cancer cell dependence on ROCK-Myosin II signaling.

Main Methods:

  • Systematic screening of ROCK inhibitor sensitivity in hundreds of cancer cell lines.
  • Transcriptomic analysis to identify gene expression patterns associated with ROCK inhibition response.
  • In vitro and in vivo validation of identified biomarkers in breast cancer, melanoma, and acute myeloid leukemia (AML).

Main Results:

  • ROCK inhibition significantly reduces the survival of highly de-differentiated, invasive cancer cells.
  • Transcriptomic analysis revealed enrichment of epithelial-to-mesenchymal transition, migration, proliferation, and inflammation genes, with decreased expression of differentiation and cell-cell junction genes (e.g., E-cadherin).
  • Acute myeloid leukemia (AML) demonstrated a high response rate to ROCK inhibitors among hematological malignancies. Biomarkers for ROCK inhibitor sensitivity were validated in breast cancer, melanoma, and AML.

Conclusions:

  • Cancer cells exhibit a unique addiction to Rho-ROCK-myosin II signaling for survival, particularly invasive and de-differentiated types.
  • ROCK inhibitors have significant pre-clinical implications for treating specific cancers.
  • Caution is advised regarding the widespread use of ROCK inhibitors in patient-derived organoid cultures due to potential depletion of critical cancer cell populations.
Keywords:
cancertherapeuticstranscriptomics

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...